New and Novel Agents for DLBCL: Bispecifics, CAR-T, and More

A roundtable discussion, moderated by Kami J. Maddocks, MD, of the James Cancer Hospital, Ohio State University Comprehensive Cancer Center, focused on treatment options for diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma, including novel emerging therapies and treatment sequencing considerations. Dr. Maddocks was joined by a panel that included Pierluigi Porcu, MD; Pamela Blair Allen, MD, MSc; and Jonathan W. Friedberg, MD.
In this segment, the panel talks about novel therapies for DLBCL, including the timing and sequencing for such treatments, patient considerations, and more.